<DOC>
	<DOC>NCT02419703</DOC>
	<brief_summary>Registry collecting data on use of The STAR™ Tumor Ablation System.</brief_summary>
	<brief_title>The STAR™ Tumor Ablation Registry</brief_title>
	<detailed_description>The STAR Prospective Registry is an observational registry to gather clinical safety and outcome data in patients with painful spinal metastases in the thoracolumbar spine (T1-L5) following targeted radiofrequency ablation (t-RFA) treatment with the STAR™ Tumor Ablation System.</detailed_description>
	<criteria>Subjects with painful spinal metastatic lesions in thoracolumbar vertebrae (T1L5) that will be treated with tRFA using the STAR™ Tumor Ablation System. Have signed informed consent Subjects under 18 years old Subjects with heart pacemakers, or other electronic device implants Subjects intended for tRFA in vertebral body levels C17</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>